Literature DB >> 29511999

MED13L-related intellectual disability: involvement of missense variants and delineation of the phenotype.

T Smol1,2, F Petit2,3, A Piton4, B Keren5, D Sanlaville6, A Afenjar7, S Baker8, E C Bedoukian9, E J Bhoj8, D Bonneau10, E Boudry-Labis1, S Bouquillon1, O Boute-Benejean2,3, R Caumes3, N Chatron6, C Colson2,3, C Coubes11, C Coutton12, F Devillard12, A Dieux-Coeslier2,3, M Doco-Fenzy13, L J Ewans14, L Faivre15,16, E Fassi17, M Field18, C Fournier4, C Francannet19, D Genevieve11, I Giurgea20, A Goldenberg21, A K Green22, A M Guerrot21, D Heron5, B Isidor23, B A Keena24, B L Krock8, P Kuentz16, E Lapi25, N Le Meur21, G Lesca6, D Li8, I Marey5, C Mignot5, C Nava5, A Nesbitt8, G Nicolas21, C Roche-Lestienne1, T Roscioli14, V Satre12, A Santani8, M Stefanova22, S Steinwall Larsen22, P Saugier-Veber21, S Picker-Minh26, C Thuillier1, A Verloes27, G Vieville12, M Wenzel24, M Willems11, S Whalen5, Y A Zarate28, A Ziegler10, S Manouvrier-Hanu2,3, V M Kalscheuer29, B Gerard4, Jamal Ghoumid30,31.   

Abstract

Molecular anomalies in MED13L, leading to haploinsufficiency, have been reported in patients with moderate to severe intellectual disability (ID) and distinct facial features, with or without congenital heart defects. Phenotype of the patients was referred to "MED13L haploinsufficiency syndrome." Missense variants in MED13L were already previously described to cause the MED13L-related syndrome, but only in a limited number of patients. Here we report 36 patients with MED13L molecular anomaly, recruited through an international collaboration between centers of expertise for developmental anomalies. All patients presented with intellectual disability and severe language impairment. Hypotonia, ataxia, and recognizable facial gestalt were frequent findings, but not congenital heart defects. We identified seven de novo missense variations, in addition to protein-truncating variants and intragenic deletions. Missense variants clustered in two mutation hot-spots, i.e., exons 15-17 and 25-31. We found that patients carrying missense mutations had more frequently epilepsy and showed a more severe phenotype. This study ascertains missense variations in MED13L as a cause for MED13L-related intellectual disability and improves the clinical delineation of the condition.

Entities:  

Keywords:  Cardiopathy; Intellectual disability; MED13L; Mediator complex

Mesh:

Substances:

Year:  2018        PMID: 29511999     DOI: 10.1007/s10048-018-0541-0

Source DB:  PubMed          Journal:  Neurogenetics        ISSN: 1364-6745            Impact factor:   2.660


  26 in total

Review 1.  MED12 related disorders.

Authors:  John M Graham; Charles E Schwartz
Journal:  Am J Med Genet A       Date:  2013-10-10       Impact factor: 2.802

2.  Genome sequencing identifies major causes of severe intellectual disability.

Authors:  Christian Gilissen; Jayne Y Hehir-Kwa; Djie Tjwan Thung; Maartje van de Vorst; Bregje W M van Bon; Marjolein H Willemsen; Michael Kwint; Irene M Janssen; Alexander Hoischen; Annette Schenck; Richard Leach; Robert Klein; Rick Tearle; Tan Bo; Rolph Pfundt; Helger G Yntema; Bert B A de Vries; Tjitske Kleefstra; Han G Brunner; Lisenka E L M Vissers; Joris A Veltman
Journal:  Nature       Date:  2014-06-04       Impact factor: 49.962

Review 3.  Impaired development of neural-crest cell-derived organs and intellectual disability caused by MED13L haploinsufficiency.

Authors:  Kagistia Hana Utami; Cecilia Lanny Winata; Axel M Hillmer; Irene Aksoy; Hoang Truong Long; Herty Liany; Elaine G Y Chew; Sinnakaruppan Mathavan; Stacey K H Tay; Vladimir Korzh; Pierre Sarda; Sonia Davila; Valere Cacheux
Journal:  Hum Mutat       Date:  2014-09-23       Impact factor: 4.878

4.  STAG1 mutations cause a novel cohesinopathy characterised by unspecific syndromic intellectual disability.

Authors:  Daphné Lehalle; Anne-Laure Mosca-Boidron; Amber Begtrup; Odile Boute-Benejean; Perrine Charles; Megan T Cho; Amanda Clarkson; Orrin Devinsky; Yannis Duffourd; Laurence Duplomb-Jego; Bénédicte Gérard; Aurélia Jacquette; Paul Kuentz; Alice Masurel-Paulet; Carey McDougall; Sébastien Moutton; Hilde Olivié; Soo-Mi Park; Anita Rauch; Nicole Revencu; Jean-Baptiste Rivière; Karol Rubin; Ingrid Simonic; Deborah J Shears; Thomas Smol; Ana Lisa Taylor Tavares; Paulien Terhal; Julien Thevenon; Koen Van Gassen; Catherine Vincent-Delorme; Marjolein H Willemsen; Golder N Wilson; Elaine Zackai; Christiane Zweier; Patrick Callier; Christel Thauvin-Robinet; Laurence Faivre
Journal:  J Med Genet       Date:  2017-01-24       Impact factor: 6.318

5.  A large permissive regulatory domain exclusively controls Tbx3 expression in the cardiac conduction system.

Authors:  Jan Hendrik van Weerd; Ileana Badi; Malou van den Boogaard; Sonia Stefanovic; Harmen J G van de Werken; Melisa Gomez-Velazquez; Claudio Badia-Careaga; Miguel Manzanares; Wouter de Laat; Phil Barnett; Vincent M Christoffels
Journal:  Circ Res       Date:  2014-06-24       Impact factor: 17.367

6.  Dosage changes of MED13L further delineate its role in congenital heart defects and intellectual disability.

Authors:  Reza Asadollahi; Beatrice Oneda; Frenny Sheth; Silvia Azzarello-Burri; Rosa Baldinger; Pascal Joset; Beatrice Latal; Walter Knirsch; Soaham Desai; Alessandra Baumer; Gunnar Houge; Joris Andrieux; Anita Rauch
Journal:  Eur J Hum Genet       Date:  2013-02-13       Impact factor: 4.246

7.  De novo mutations in moderate or severe intellectual disability.

Authors:  Fadi F Hamdan; Myriam Srour; Jose-Mario Capo-Chichi; Hussein Daoud; Christina Nassif; Lysanne Patry; Christine Massicotte; Amirthagowri Ambalavanan; Dan Spiegelman; Ousmane Diallo; Edouard Henrion; Alexandre Dionne-Laporte; Anne Fougerat; Alexey V Pshezhetsky; Sunita Venkateswaran; Guy A Rouleau; Jacques L Michaud
Journal:  PLoS Genet       Date:  2014-10-30       Impact factor: 5.917

8.  Prevalence and architecture of de novo mutations in developmental disorders.

Authors: 
Journal:  Nature       Date:  2017-01-25       Impact factor: 49.962

9.  De novo genic mutations among a Chinese autism spectrum disorder cohort.

Authors:  Tianyun Wang; Hui Guo; Bo Xiong; Holly A F Stessman; Huidan Wu; Bradley P Coe; Tychele N Turner; Yanling Liu; Wenjing Zhao; Kendra Hoekzema; Laura Vives; Lu Xia; Meina Tang; Jianjun Ou; Biyuan Chen; Yidong Shen; Guanglei Xun; Min Long; Janice Lin; Zev N Kronenberg; Yu Peng; Ting Bai; Honghui Li; Xiaoyan Ke; Zhengmao Hu; Jingping Zhao; Xiaobing Zou; Kun Xia; Evan E Eichler
Journal:  Nat Commun       Date:  2016-11-08       Impact factor: 14.919

10.  Large-scale discovery of novel genetic causes of developmental disorders.

Authors: 
Journal:  Nature       Date:  2014-12-24       Impact factor: 69.504

View more
  9 in total

1.  Comprehensive genetic analysis of 57 families with clinically suspected Cornelia de Lange syndrome.

Authors:  Hiromi Aoi; Takeshi Mizuguchi; José Ricard Ceroni; Veronica Eun Hue Kim; Isabel Furquim; Rachel S Honjo; Takuma Iwaki; Toshifumi Suzuki; Futoshi Sekiguchi; Yuri Uchiyama; Yoshiteru Azuma; Kohei Hamanaka; Eriko Koshimizu; Satoko Miyatake; Satomi Mitsuhashi; Atsushi Takata; Noriko Miyake; Satoru Takeda; Atsuo Itakura; Débora R Bertola; Chong Ae Kim; Naomichi Matsumoto
Journal:  J Hum Genet       Date:  2019-07-23       Impact factor: 3.172

2.  Genetic Aspects of Small for Gestational Age Infants Using Targeted-Exome Sequencing and Whole-Exome Sequencing: A Single Center Study.

Authors:  Su-Jung Park; Narae Lee; Seong-Hee Jeong; Mun-Hui Jeong; Shin-Yun Byun; Kyung-Hee Park
Journal:  J Clin Med       Date:  2022-06-27       Impact factor: 4.964

Review 3.  Transcription Pause and Escape in Neurodevelopmental Disorders.

Authors:  Kristel N Eigenhuis; Hedda B Somsen; Debbie L C van den Berg
Journal:  Front Neurosci       Date:  2022-05-09       Impact factor: 5.152

Review 4.  MED12-Related (Neuro)Developmental Disorders: A Question of Causality.

Authors:  Stijn van de Plassche; Arjan Pm de Brouwer
Journal:  Genes (Basel)       Date:  2021-04-28       Impact factor: 4.096

5.  Variants in MED12L, encoding a subunit of the mediator kinase module, are responsible for intellectual disability associated with transcriptional defect.

Authors:  Mathilde Nizon; Vincent Laugel; Kevin M Flanigan; Matthew Pastore; Megan A Waldrop; Jill A Rosenfeld; Ronit Marom; Rui Xiao; Amanda Gerard; Olivier Pichon; Cédric Le Caignec; Marion Gérard; Klaus Dieterich; Megan Truitt Cho; Kirsty McWalter; Susan Hiatt; Michelle L Thompson; Stéphane Bézieau; Alexandrea Wadley; Klaas J Wierenga; Jean-Marc Egly; Bertrand Isidor
Journal:  Genet Med       Date:  2019-06-03       Impact factor: 8.822

Review 6.  Report of a de novo c.2605C > T (p.Pro869Ser) change in the MED13L gene and review of the literature for MED13L-related intellectual disability.

Authors:  Zhi Yi; Ying Zhang; Zhenfeng Song; Hong Pan; Chengqing Yang; Fei Li; Jiao Xue; Zhenghai Qu
Journal:  Ital J Pediatr       Date:  2020-07-09       Impact factor: 2.638

7.  Somatic and de novo Germline Variants of MEDs in Human Neural Tube Defects.

Authors:  Tian Tian; Xuanye Cao; Yongyan Chen; Lei Jin; Zhiwen Li; Xiao Han; Ying Lin; Bogdan J Wlodarczyk; Richard H Finnell; Zhengwei Yuan; Linlin Wang; Aiguo Ren; Yunping Lei
Journal:  Front Cell Dev Biol       Date:  2021-03-04

8.  MED13L-related intellectual disability due to paternal germinal mosaicism.

Authors:  Beáta Bessenyei; István Balogh; Attila Mokánszki; Anikó Ujfalusi; Rolph Pfundt; Katalin Szakszon
Journal:  Cold Spring Harb Mol Case Stud       Date:  2022-01-10

Review 9.  Potential roles of mediator Complex Subunit 13 in Cardiac Diseases.

Authors:  Wenqian Zhou; He Cai; Jia Li; He Xu; Xiang Wang; Hongbo Men; Yang Zheng; Lu Cai
Journal:  Int J Biol Sci       Date:  2021-01-01       Impact factor: 6.580

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.